NVNO · All filings · Read this filing

What changed 10-Q

Item 5. Other Information

2021-11-12 compared with 2021-08-11 · 8 added, 9 removed, 17 unchanged (50% of the section changed)

3 unchanged sentences

of Item 601 of Regulation S-K.

Certification

of Chief Executive Officer pursuant to Rule 13a-14(a) or Rule 15d-14(a) of the Exchange Act.

Certification

of Chief Financial Officer pursuant to Rule 13a-14(a) or Rule 15d-14(a) of the Sarbanes-Oxley Act.

Certification

of Chief Executive Officer and Chief Financial Officer pursuant to Rule 13a-14(a) or Rule 15d-14(a) of the Exchange Act**

Certification of Chief Executive Officer pursuant to Rule 13a-14(a) or Rule 15d-14(a) of the Exchange Act.

Certification of Chief Financial Officer pursuant to Rule 13a-14(a) or Rule 15d-14(a) of the Sarbanes-Oxley Act.

Certification of Chief Executive Officer and Chief Financial Officer pursuant to Rule 13a-14(a) or Rule 15d-14(a) of the Exchange Act**

Instance Document*

4 unchanged sentences

Taxonomy Extension Presentation Linkbase Document*

Cover Page Interactive Data

File (embedded within the Inline XBRL document)

and not filed herewith.

1 unchanged sentence

its behalf by the undersigned, thereunto duly authorized.

August 10, 2021

JAFFE LABORATORIES, INC.

November 10, 2021

MEDICAL CORPORATION

Robert Berman

1 unchanged sentence

Executive Officer)

Financial Officer

Chief Financial Officer

Financing and Accounting Officer)

Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.